Immune Tolerance Study With Aldurazyme® (Laronidase)
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if treatment with an antigen-specific immunosuppressive
can decrease or stop an antibody response to laronidase (Aldurazyme®) during enzyme
replacement therapy with laronidase in severe Mucopolysaccharidosis I (MPS I) participants.